These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 1311351)

  • 1. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala.
    Navin TR; Arana BA; Arana FE; Berman JD; Chajón JF
    J Infect Dis; 1992 Mar; 165(3):528-34. PubMed ID: 1311351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis.
    Hepburn NC; Tidman MJ; Hunter JA
    Trans R Soc Trop Med Hyg; 1994; 88(6):700-3. PubMed ID: 7886779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
    El-Sayed M; Anwar AE
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis.
    Saenz RE; Paz H; Berman JD
    Am J Med; 1990 Aug; 89(2):147-55. PubMed ID: 2166429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of New World cutaneous and mucosal leishmaniases.
    Berman JD
    Clin Dermatol; 1996; 14(5):519-22. PubMed ID: 8889330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety].
    Saldanha AC; Romero GA; Merchan-Hamann E; Magalhães AV; Macedo Vde O
    Rev Soc Bras Med Trop; 1999; 32(4):383-7. PubMed ID: 10495667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Effect Of Oral Allopurinol And Intralesional Sodium Stibogluconate In The Treatment Of Cutaneous Leishmaniasis.
    Rashid HU; Ullah I; Adeeb H; Zeb M; Mohammad A; Rehman N
    J Ayub Med Coll Abbottabad; 2020; 32(4):558-561. PubMed ID: 33225663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
    Grogl M; Thomason TN; Franke ED
    Am J Trop Med Hyg; 1992 Jul; 47(1):117-26. PubMed ID: 1322070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-gamma antibody.
    Nabors GS; Farrell JP
    Am J Trop Med Hyg; 1995 Jul; 53(1):55-60. PubMed ID: 7625533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium stibogluconate (Pentostam) overdose during treatment of American cutaneous leishmaniasis.
    Herwaldt BL; Kaye ET; Lepore TJ; Berman JD; Baden HP
    J Infect Dis; 1992 May; 165(5):968-71. PubMed ID: 1314873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure.
    Grögl M; Oduola AM; Cordero LD; Kyle DE
    Exp Parasitol; 1989 Jul; 69(1):78-90. PubMed ID: 2543590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
    Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E
    J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [American cutaneous leishmaniasis: special features in diagnosis and therapy].
    Bormann G; William T; Schulz A; Marsch W; Gaber G
    Dtsch Med Wochenschr; 2003 Oct; 128(40):2065-8. PubMed ID: 14523685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies.
    Herwaldt BL; Berman JD
    Am J Trop Med Hyg; 1992 Mar; 46(3):296-306. PubMed ID: 1313656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers.
    Solomon M; Pavlotzky F; Barzilai A; Schwartz E
    J Am Acad Dermatol; 2013 Feb; 68(2):284-9. PubMed ID: 22858005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental treatment with sodium stibogluconate of hamsters infected with Leishmania (Leishmania) chagasi and Leishmania (Leishmania) amazonensis.
    de Figueiredo EM; Costa e Silva J; Brazil RP
    Rev Soc Bras Med Trop; 1999; 32(2):191-3. PubMed ID: 10228371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case 4-2005: sodium stibogluconate for cutaneous leishmaniasis.
    Hartzell JD; Aronson N
    N Engl J Med; 2005 May; 352(18):1929. PubMed ID: 15872214
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.
    Wortmann G; Miller RS; Oster C; Jackson J; Aronson N
    Clin Infect Dis; 2002 Aug; 35(3):261-7. PubMed ID: 12115091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis.
    Ballou WR; McClain JB; Gordon DM; Shanks GD; Andujar J; Berman JD; Chulay JD
    Lancet; 1987 Jul; 2(8549):13-6. PubMed ID: 2885505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous leishmaniasis in British troops from Belize.
    Hepburn NC; Tidman MJ; Hunter JA
    Br J Dermatol; 1993 Jan; 128(1):63-8. PubMed ID: 8381299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.